Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>

ABSTRACT Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Toth, Nichole K. Stewart, Clyde Smith, Sergei B. Vakulenko
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/8081a353a6874a4090b4509fee48d0d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8081a353a6874a4090b4509fee48d0d5
record_format dspace
spelling oai:doaj.org-article:8081a353a6874a4090b4509fee48d0d52021-11-15T15:52:18ZIntrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>10.1128/mBio.01803-182150-7511https://doaj.org/article/8081a353a6874a4090b4509fee48d0d52018-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01803-18https://doaj.org/toc/2150-7511ABSTRACT Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β-lactamases, i.e., CDDs, which are intrinsic to this species. We studied two CDD enzymes, CDD-1 and CDD-2, and showed that they display broad-spectrum, high catalytic efficiency against various β-lactam antibiotics, including penicillins and expanded-spectrum cephalosporins. We demonstrated that the cdd genes are poorly expressed under the control of their own promoters and contribute only partially to the observed resistance to β-lactams. However, when the cdd1 gene was expressed under the control of efficient promoters in the antibiotic-sensitive Clostridium cochlearium strain, it produced high-level resistance to β-lactams. Taken together, the results determined in this work demonstrate the existence in C. difficile of intrinsic class D β-lactamases which constitute a reservoir of highly potent enzymes capable of conferring broad-spectrum, clinically relevant levels of resistance to β-lactam antibiotics. This discovery is a significant contribution to elucidation of the mechanism(s) of resistance of the clinically important pathogen C. difficile to β-lactam antibiotics. IMPORTANCE C. difficile is a spore-forming anaerobic bacterium which causes infection of the large intestine with high mortality rates. The C. difficile infection is difficult to prevent and treat, as the pathogen is resistant to many antimicrobial agents. Prolonged use of β-lactam antibiotics for treatment of various infectious diseases triggers the infection, as these drugs suppress the abundance of protective gut bacteria, allowing the resistant C. difficile bacteria to multiply. While resistance of C. difficile to β-lactam antibiotics plays the major role in the development of the disease, the mechanism of resistance is unknown. The significance of our research is in the discovery in C. difficile of β-lactamases, enzymes that destroy β-lactam antibiotics. These findings ultimately can help to combat deadly C. difficile infections.Marta TothNichole K. StewartClyde SmithSergei B. VakulenkoAmerican Society for MicrobiologyarticleClostridium difficileantibiotic resistancebeta-lactamasesMicrobiologyQR1-502ENmBio, Vol 9, Iss 6 (2018)
institution DOAJ
collection DOAJ
language EN
topic Clostridium difficile
antibiotic resistance
beta-lactamases
Microbiology
QR1-502
spellingShingle Clostridium difficile
antibiotic resistance
beta-lactamases
Microbiology
QR1-502
Marta Toth
Nichole K. Stewart
Clyde Smith
Sergei B. Vakulenko
Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
description ABSTRACT Clostridium difficile is the causative agent of the deadly C. difficile infection. Resistance of the pathogen to β-lactam antibiotics plays a major role in the development of the disease, but the mechanism of resistance is currently unknown. We discovered that C. difficile encodes class D β-lactamases, i.e., CDDs, which are intrinsic to this species. We studied two CDD enzymes, CDD-1 and CDD-2, and showed that they display broad-spectrum, high catalytic efficiency against various β-lactam antibiotics, including penicillins and expanded-spectrum cephalosporins. We demonstrated that the cdd genes are poorly expressed under the control of their own promoters and contribute only partially to the observed resistance to β-lactams. However, when the cdd1 gene was expressed under the control of efficient promoters in the antibiotic-sensitive Clostridium cochlearium strain, it produced high-level resistance to β-lactams. Taken together, the results determined in this work demonstrate the existence in C. difficile of intrinsic class D β-lactamases which constitute a reservoir of highly potent enzymes capable of conferring broad-spectrum, clinically relevant levels of resistance to β-lactam antibiotics. This discovery is a significant contribution to elucidation of the mechanism(s) of resistance of the clinically important pathogen C. difficile to β-lactam antibiotics. IMPORTANCE C. difficile is a spore-forming anaerobic bacterium which causes infection of the large intestine with high mortality rates. The C. difficile infection is difficult to prevent and treat, as the pathogen is resistant to many antimicrobial agents. Prolonged use of β-lactam antibiotics for treatment of various infectious diseases triggers the infection, as these drugs suppress the abundance of protective gut bacteria, allowing the resistant C. difficile bacteria to multiply. While resistance of C. difficile to β-lactam antibiotics plays the major role in the development of the disease, the mechanism of resistance is unknown. The significance of our research is in the discovery in C. difficile of β-lactamases, enzymes that destroy β-lactam antibiotics. These findings ultimately can help to combat deadly C. difficile infections.
format article
author Marta Toth
Nichole K. Stewart
Clyde Smith
Sergei B. Vakulenko
author_facet Marta Toth
Nichole K. Stewart
Clyde Smith
Sergei B. Vakulenko
author_sort Marta Toth
title Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
title_short Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
title_full Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
title_fullStr Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
title_full_unstemmed Intrinsic Class D β-Lactamases of <italic toggle="yes">Clostridium difficile</italic>
title_sort intrinsic class d β-lactamases of <italic toggle="yes">clostridium difficile</italic>
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/8081a353a6874a4090b4509fee48d0d5
work_keys_str_mv AT martatoth intrinsicclassdblactamasesofitalictoggleyesclostridiumdifficileitalic
AT nicholekstewart intrinsicclassdblactamasesofitalictoggleyesclostridiumdifficileitalic
AT clydesmith intrinsicclassdblactamasesofitalictoggleyesclostridiumdifficileitalic
AT sergeibvakulenko intrinsicclassdblactamasesofitalictoggleyesclostridiumdifficileitalic
_version_ 1718427285859598336